The pharmaceutical industry is suffering from an unprecedented scale of infectious disease outbreak with COVID-19. The executives are feeling restless from continuing to work from home and their stress of sales performance is deepening day by day.

Amid worldwide pandemic, pharmaceutical companies are struggling to confirm transaction agreement or prescription statistics, and sales people unable to meet their accounts have substituted their everyday work with detailed simulation, academic education and other tests besides regular reporting.

Many companies are recommending employees to take days off, but most of them have no intention to do so. When the government is urging for social di